Locally ablative therapies for primary radiation failures: A review and critical assessment of the efficacy

Current Urology Reports

Volumn 8, Issue 3, 2007, Pages 217-223

  Huang, William C ^b   Lee, Courtney L ^b   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETER ABLATION; CRYOTHERAPY; DYSURIA; ERECTILE DYSFUNCTION; HEMATURIA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMPOTENCE; INCONTINENCE; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; LONG TERM CARE; MORBIDITY; OBSTRUCTIVE UROPATHY; PERINEUM INJURY; PROSTATE CANCER; RECTUM DISEASE; RECTUM HEMORRHAGE; RECURRENT DISEASE; SALVAGE THERAPY; SEXUAL DYSFUNCTION; SKIN EXFOLIATION; TREATMENT FAILURE; TUMOR BIOPSY; URETHRA FISTULA; URETHRA STRICTURE; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; UROGENITAL TRACT DISEASE; MALE; PROSTATE TUMOR; REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE; ULTRASOUND THERAPY;

BRACHYTHERAPY; CRYOTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 34248523173     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0009-5     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
2. Brandeis J, Pashos CL, Henning JM, Litwin MS: A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 2000, 89:1792-1799.
3. D'Amico AV, Whittington R, Malkowicz SB, et al.: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280:969-974.
4. Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 1997, 15:230-238.
5. Zagars GK, Pollack A, von Eschenbach AC: Prostate cancer and radiation therapy: the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 1995, 33:23-35.
6. Fuks Z, Leibel SA, Wallner KE, et al.: The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys 1991, 21:537-547.
7. Grossfeld GD, Li YP, Lubeck DP, et al.: Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2002, 168:530-535.
8. Sylvester J, Grimm P, Blasco J, et al.: The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States. Urology 2001, 58(2 Suppl l):65-70.
9. Saliken JC, Donnelly BJ, Rewcastle JC: The evolution and state of modern technology for prostate cryosurgery. Urology 2002, 60(2 Suppl 1):26-33.
10. Poissonnier L, Chapelon JY, Rouviere O, et al.: Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007, 51:381-387.
11. Zelefsky MJ, Kuban DA, Levy LB, et al.: Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007, 67:327-333.
12. Bahn DK, Lee F, Badalament R, et al.: Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002, 60(2 Suppl 1):3-11.
13. Huang W, Kuroiwa K, Serio A, et al.: The anatomic and pathologic characteristics of irradiated prostate cancers may influence the oncologic efficacy of salvage ablative therapies. J Urol 2007, In press. The only published mapping study of whole-mounted salvage radical prostatectomy specimens demonstrating the anatomic and pathologic characteristics of irradiated prostate cancers.
14. Beyer DC: Salvage brachytherapy after external-beam irradiation for prostate cancer. Oncology (Williston Park) 2004, 18:151-158; discussion 158-160, 163-164.
15. Gheiler EL, Tefilli MV, Tiguert R, et al.: Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 1998, 51:789-795.
16. Ward JF, Sebo TJ, Blute ML, Zincke H: Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005, 173:1156-1160.
17. Bianco FJ Jr, Scardino PT, Stephenson AJ, et al.: Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:448-453. Gives the long-term oncologic results of one the largest salvage radical prostatectomy series.
18. Stephenson AJ, Eastham JA: Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 2005, 23:8198-8203.
19. Potters L, Morgenstern C, Calugaru E, et al.: 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 2005, 173:1562-1566.
20. Beyer DC: Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol 2003, 13:158-165.
21. Lee B, Shinohara K, Weinberg V, et al.: Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2006, Dec 28 [Epub ahead of print]. Discusses the shortcomings and advances in salvage brachytherapy and describes an early experience with HDR brachytherapy in the salvage setting.
22. Grado GL, Collins JM, Kriegshauser JS, et al.: Salvage brachytherapy for localized prostate cancer after radio-therapy failure. Urology 1999, 53:2-10.
23. Beyer DC: Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 1999, 54:880-883.
24. Wong WW, Buskirk SJ, Schild SE, et al.: Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 2006, 176:2020-2024.
25. Mouraviev V, Polascik TJ: Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol 2006, 16:152-156.
26. Katz A, Ghafar MA: Selection of salvage cryotherapy patients. Rev Urol 2002, 4(Suppl 2):S18-S23.
27. Donnelly BJ, Saliken JC: Salvage cryosurgery: how I do it. Rev Urol 2002, 4(Suppl 2):S24-29.
28. Chin JL, Touma N: Current status of salvage cryoablation for prostate cancer following radiation failure. Technol Cancer Res Treat 2005, 4:211-216.
29. Ghafar MA, Johnson CW, De La Taille A, et al.: Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001, 166:1333-1337; discussion 1337-1338.
30. Chin JL, Pautler SE, Mouraviev V, et al.: Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001, 165(6 Pt 1):1937-1941; discussion 1941-1932.
31. Bahn DK, Lee F, Silverman P, et al.: Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003, 2:111-114.
32. Donnelly BJ, Saliken JC, Ernst DS, et al.: Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 2005, 8:235-242.
33. Pisters LL, von Eschenbach AC, Scott SM, et al.: The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997, 157:921-925.
34. Izawa JI, Madsen LT, Scott SM, et al.: Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002, 20:2664-2671.
35. Katz A, Prepelica K, McKiernan JM, et al.: Salvage cryosurgical ablation of the prostate (TCAP) for patients failing radiation: efficacy and tolerability. Presented at the American Urological Association Annual Meeting. Atlanta, GA; May 20-25, 2006.
36. Chin JL, Touma N, Pautler SE, et al.: Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol 2003, 170(4 Pt 1):1199-1202.
37. Colombel M, Gelet A: Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 2004, 7:289-294.
38. Blana A, Walter B, Rogenhofer S, Wieland WF: High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004, 63:297-300.
39. Chaussy C, Thuroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003, 4:248-252.
40. Gelet A, Chapelon JY, Bouvier R, et al.: Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001, 40:124-129.
41. Acher PL, Hodgson DJ, Murphy DG, Cahill DJ: High-intensity focused ultrasound for treating prostate cancer. BJU Int 2007, 99:28-32.
42. Gelet A, Chapelon JY, Poissonnier L, et al.: Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004, 63:625-629. Describes the largest published experience on HIFU used as local salvage therapy for recurrent prostate cancer following primary radiation therapy.
43. Murat FJ, Chapelon JY, Poissonnier L, et al.: Salvage HIFU for radiorecurrent prostate cancer: factors influencing the outcome [abstract]. Eur Urol (Suppl) 2006, 5:133.
44. Chaussy C, Thuroff S: Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001, 15:437-440; discussion 447-438.
45. Stephenson AJ, Scardino PT, Bianco FJ Jr, et al.: Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004, 172(6 Pt 1):2239-2243.
46. Amling CL, Lerner SE, Martin SK, et al.: Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999, 161:857-862; discussion 862-853.